Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest Articles A cross-sectional survey of relationship between serum TSH level and blood pressure
Journal of Human Hypertension, 06/29/09
Liu D et al. – The prevalence of hypertension in subclinical hypothyroidism group was significantly higher than in euthyroid group in females. Change of thyroid-stimulating hormone (TSH) in normal range did not affect blood pressure.
Methods- Study of the relationship between different levels of TSH and blood pressure in pts with subclinical hypothyroidism and euthyroidism
- Questionnaire survey for 1319 pts
- Measurements of blood pressure, height, and body weight
- Blood samples for serum TSH
- Assessment of FT3 and FT4 if abnormal TSH
- Pts classified as euthyroid group and subclinical hypothyroidism group
- Euthyroid group: group A (TSH 0.3–0.99 mIU l-1), group B (TSH 1.0–1.9 mIU l-1) and group C (TSH 1.91–4.8 mIU l-1)
- Different levels of serum TSH had no relation with systolic blood pressure (SBP) and diastolic blood pressure (DBP)
- Prevalence of hypertension in subclinical hypothyroidism group significantly higher than euthyroid group in females (41.3 vs 25.6%)
- Risk of hypertension in subclinical hypothyroidism group significantly higher than that in euthyroid group after adjusted for age, gender, smoking status, HOMA-IR (homoeostasis model assessment of insulin resistance) and body mass index
- Association stronger in females; no statistical significance in males
- Within normal range of TSH, both SBP and DBP similar among the 3 groups
- Prevalence and risk of hypertension also similar among the 3 groups
Today in Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial
The Lancet, 10/27/09
Obesity-Related Cardiorenal Syndrome
The Journal of Clinical Hypertension, 10/20/09
Pravastatin and cardiovascular risk in moderate chronic kidney disease
Atherosclerosis, 10/07/09
Sponsor
Article Search
Sponsor